Clinical Research

Dr. Mohamed Kamal

• M. E. M. Abo, N. A. K. Shah, V. Balakrishnan, M. Kamal, A. Abdelaziz and K. Haruna, “SSA-SDA: Subjectivity and Sentiment Analysis of Sudanese Dialect Arabic,” 2019 International Conference on Computer and Information Sciences (ICCIS), Sakaka, Saudi Arabia, 2019, pp. 1-5.doi: 10.1109/ICCISci.2019.8716466
• Alfaar AS, Nour R, Bakry MS, Kamal M, Hassanain O, Labib RM, Rashed WM, Elzomor H, Alieldin A, Taha H, Zaghloul MS, Ezzat S, AboElnaga S. A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. Int Ophthalmol. 2017 Feb;37(1):111-118. doi: 10.1007/s10792-016-0233-4.Epub 2016 Apr 25. PubMed PMID: 27113056.
• Ezzat S, Kamal M, El-Khateeb N, El-Beltagy M, Taha H, Refaat A, Awad M, Abouelnaga S, Zaghloul MS. Pediatric brain tumors in a low/middle income country: does it differ from that in developed world? J Neurooncol. 2016 Jan;126(2):371-6. doi: 10.1007/s11060-015-1979-7. Epub 2015 Oct 29. PubMed PMID: 26514358.
• kamal, M., Abdelhameed, F., Yasser, N. and Hassanain, O. (2016, August). Discrete Event Simulation using R: Hospital Capacity Planning. [online] Codeproject.com. Available at: https://www.codeproject.com/Articles/1111093/Discrete-Event-Simulation-using-R-Oncology-
• El Beltagy MA, Atteya MM, El-Haddad A, Awad M, Taha H, Kamal M, El Naga SA. Surgical and clinical aspects of cerebellar pilomyxoid-spectrum astrocytomas in children. Childs Nerv Syst. 2014 Jun;30(6):1045-53. doi: 10.1007/s00381-014-2366-y. Epub 2014 Feb 5. PubMed PMID: 24497195.
• Kamal, M. and Bakery, M. (2012, November). The use of MS Chart Control and VB.NET for Statistical Purposes: Plotting Kaplan-Meier Estimate.. [online] Codeproject.com. Available at: https://www.codeproject.com/Articles/491394/The-use-of-MS-Chart-Control-and-VB-NET-for-Statist

Dr. Wafaa Rashed

• ORCID: orcid.org/0000-0001-7531-2840

Dr. Omneya Ahmed

• Discrete Event Simulation using R: Hospital Capacity Planning. Posted: 27 Jul 2016 http://web4.codeproject.com/Articles/1111093/Discrete-Event-Simulation-using-R-Hospital-Capacit
• Real time detection of medication interaction using VB.NET Posted: 7 May 2013
• Incidence, risk factors, and outcome of bloodstream infections during the first 100 days post‐pediatric allogeneic and autologous hematopoietic stem cell transplantations. Youssef A, Hafez H, Madney Y, Elanany M, Hassanain O, Lehmann LE et al. Pediatr Transplant. 2019 Nov 4
• Prognostic Factors and Treatment Outcome of Pediatric Anaplastic Large Cell Lymphoma Treated at the Children Cancer Hospital Egypt. Abdel Rahman H, El Semary S, Sedky M, Atteya I, El Kinaaie N, Hassanain O, et al J Pediatr Hematol Oncol.2019 Oct
• Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma. Yehia M, Taha H, Salama A, Amer N, Mosaab A, Hassanain O, et al. Nature Sci Rep Aug 2019 vol: 9 (1) pp: 12605
• Role of 18F- Fluorodeoxyglucose positron emission tomography computed tomography and Magnetic Resonance Imaging in Prediction of Response to Neo- Adjuvant Chemotherapy in Pediatric Osteosarcoma
• World J Nucl Med- Ahead of print
• Day +100 Platelet Count Predicts Survival Post Allogeneic Hematopoietic Stem Cell Transplantation in Children with Hematologic Malignancies. Moneib H, Hafez H, Abdalla A, Hassanain O. Lehmann L, ElHaddad A. Clin Lymphoma Myeloma Leuk. 2019 Jan
• Outcome of Childhood Acute Megakaryoblastic Leukemia: Children’s Cancer Hospital Egypt 57357 Experience .Maarouf N, Mahmoud S, Khedr R, Lehmann L, Shaaban K, Ibrahim S, Hassanain O, Nader N, Elhaddad A. Clin Lymphoma Myeloma Leuk. 2018 Dec
• Planning Today for Tomorrow’s Research: Analysis of Factors Influencing Participation in a Pediatric Cancer Research Biorepository. Labib RM, Hassanain O, Alaa M, Ahmed S, Abou El-Naga S. Front Oncol. 2018 Jan 12
• A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.’ Alfaar AS, Nour R, Bakry MS, Kamal M, Hassanain O, Labib RM, et al. Int Ophthalmol. 2017 Feb 25 ;37(1):111–8.
• Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin’s lymphoma. CCHE experience. Abdel Rahman H, Sedky M, Hamoda A, Raafat T, Youssef A, Omar W, Hassanain O et al. J Egypt Natl Canc Inst. 2016 Jun ;28(2):95–9.
• PET/CT and MIBG scans in diagnosis and management of Neuroblastoma. Fawzy M, Moussa E, Hamouda A, Zaher A, Hassanain O, Azmy S, J Solid Tumors. 2015 May 22;5(2): p32
• Pediatric mature B-cell non Hodgkin lymphoma treatment with LMB-96 protocol. The Children Cancer Hospital Egypt experience. Abdel Rahman H, Moussa E, Sedky M, Gouda I, Elwakeel M, Hassanain O. Int J Cancer Ther Oncol. 2015 Apr 26 ;3(2):3215.

Posters and Oral Presentations

• High incidence of MRD Gram-negative bacteremia in children during AML induction at Children Cancer Hospital Egypt 57357. ASPHO 2019.
• Clinical outcomes of childhood Megakaryoplastic leukemia: The Children Cancer Hospital Egypt 57357 experience. EHA congress 2017. Maarouf N, Mahmoud S, Abdelaziz R, Lehmann L, Shaaban K, Hassanain O, Nader N, Elhaddad A.
• Outcome of Newly Diagnosed Osteosarcoma with pulmonary metastasis in Children and Adolescent. Presentation, Oral presentation EMSOS 2017. Ahmed S, El Shafeiy M, Taha G, El Ghoneimy A, Taha H, Zaky I, El Sherbiny M, Hassanain O, Kamal N, Zamzam M.
• Outcome of Ewing’s Sarcoma Family of Tumors of the Chest Wall in Pediatric Patients, Children Cancer Hospital, Egypt, 57357 (CCHE) Experience. Oral Presentation, EMSOS 2017. Ahmed S, ElNadi E, ElShafeiy M, Taha G,Zaghloul M, Zaky I, Taha H, Hassanain O, Kamal N, Zamzam M.
• Prognostic factors and treatment outcome of pediatric Anaplastic Large Cell Lymphoma treated in CCHE. EHA congress 2016. nAbdelrahman H, Semary S, Atteya I, Sedky M, Talaat S, Hassanain O
• Burkitt Lymphoma in Children: Is a Second Cycle Pre-Induction Chemotherapy Effective in Critically ILL Children? Moussa E, Hamoda A, Semary S, Romeih M, Amin R, Hassanain O. PEDIATRIC BLOOD & CANCER 2016 Jun. 63, S36-S36.
• Advancing Clinical Oncology Practice in Developing Countries: Integrating Research Informatics for Continuous Process Improvement. ESMO 2012 Congress, 28 September - 2 October, Vienna, Austria. Kamal M, Hassanain O, Sabry O.
• Building the First ELearning Pediatric Oncology Clinical Pharmacy Program for Developing Countries", Poster Discussion at the European Conference of Oncology Pharmacy, ECOP 2012, Hassanain O, Kamal M, Adel N, Abouelnaga S, Samir A.
• Pediatric Non-Hodgkin’s Lymphoma, Children Cancer Hospital- Egypt Experience” Poster Presentation at the 44th Congress of the International Society of Pediatric Oncology, SIOP 2012 Abdel Rahman H, Moussa E, Sedky M, Gouda I, Elwakeel M, Hassanain O.
• Integrating Treatment Protocol Monitoring System with Real-Time Statistics: A Research Oriented In-House Developed Solution." Abstract, oral presentation, 15th International Symposium on Pediatric Neuro-Oncology – ISPNO 2012 Kamal M, Hassanain O, Sabry M.
• Toxicity Profile of Rituximab among Pediatric Patients with Newly Diagnosed Mature B-cell Non-Hodgkin’s Lymphoma: A Retrospective Study at the Children’s Cancer Hospital Egypt." Poster presentation at 21st PPAG 2012. Hassanain O, Kamal O, Kamal S, Abdelrahman H, Abouelnaga S.
• Treatment Protocols' Monitoring Solution for Real-Time Tracking of Pediatric Cancer Patients: A Research Oriented System." Poster presentation at the 21st Pediatric Pharmacy Advocacy Group Annual Meeting, PPAG 2012. Kamal M, Hassanain O, Abouelnaga S, Hussein H, Hosny H.

Dr. Nada Elkhateeb

• 2016: Paper “Treatment and Outcome in 65 Children with Optic Pathway Gliomas”. Published by of world neurosurgery journal.
• 2015: Paper “Pediatric brain tumors in a low/middle income country: does it differ from that in developed world?”. Published by the journal of neurooncology.
• 2014: Paper: " Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A randomized controlled trial. Published by Radiotherapy and Oncology Journal.

Abstracts:

• Hypo fractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A prospective controlled randomized trial. Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2012.
• Risk adapted treatment for medulloblastoma in children older than 3 years: children's cancer hospital Egypt (CCHE) 57357 experience. Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2012 DV-01.

Poster presentations:

• Hypo fractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A prospective controlled randomized trial. At the 15th international symposium on pediatric neuro-oncology (ISPNO), May 2012.

Oral presentations:

• Hypo fractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): A prospective controlled randomized trial. At the 44th Congress of the International Society for Paediatric Oncology (SIOP), October 2012.
• 2010: Paper about "Endoscopic third ventriculostomy before tumor surgery in children with Posterior fossa tumors, CCHE experience" published by Child's nervous system journal.